Renal Outcome in Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass

被引:2
|
作者
Alqarni, Mohammed S. [1 ]
Ghunaim, Abdullah H. [2 ]
Abukhodair, Abdulkarim W. [1 ]
Fernandez, Jose Andres [3 ]
Bennett, Sean R. [3 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Med, Jeddah, Saudi Arabia
[2] King Abdulaziz Univ, Coll Med, Med, Jeddah, Saudi Arabia
[3] King Abdullah Med City, King Faisal Cardiac Ctr, Anesthesiol, Jeddah, Saudi Arabia
关键词
renal outcome; cardiac surgery; cardiopulmonary bypass; kingdom of saudi arabia (ksa); CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; GLOBAL BURDEN; RISK; DURATION;
D O I
10.7759/cureus.9015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Renal dysfunction is a significant variable in determining the outcome of surgery, such as cardiopulmonary bypass graft and valvular replacement, used to treat cardiovascular diseases. In Saudi Arabia, the incidence of renal failure and diabetes is higher than in most western populations. Our aim is to determine the renal outcome of patients who underwent cardiac surgery at King Faisal Cardiac Center from 2014 to 2017. Methods This a retrospective cohort study using a non-probability consecutive sampling technique for selection of the study population to assess the renal outcome in cardiac surgery patients using cardiopulmonary bypass from May 2014 to June 2017 in King Faisal Cardiac Center, Jeddah. Patients older than 18 years of age undergoing cardiac surgery, with available data, were included. Categorical variables were summarized by percentages and frequencies, and continuous variables by means and standard deviations, or medians and interquartile ranges if their distributions were skewed. Logistic regression was done with post-op renal impairment as the dependent variable and pre-op renal dysfunction, age, gender, smoking status, diabetes, hypertension, dyslipidemia, and cardiopulmonary bypass time as independent variables. Results Our sample size included 244 patients who underwent cardiac surgery in this study period; their mean age was 60.5 (SD =7.5) with a mean body mass index (BMI) of 28.62 (SD=5.19). Among our population, 73% (n = 179) were males and 27% (n =66) were females. Two percent (2%) of patients (n = 5) died within 30 days, 4% of patients (n = 10) with temporary dialysis, 8% of patients (n = 19) with postoperative renal dysfunction, and no patients with permanent dialysis. The data showed a significant relationship between levels of creatinine preoperatively and postoperative renal dysfunction (p-value = 0.0001, OR=1.05, 95% CI of 1.031 to 1.064). Conclusion The main predictor of poor renal outcomes for cardiac surgery is preoperative creatinine. While other factors, such as age, gender, body mass index, cardiopulmonary bypass time, diabetes, hypertension, and dyslipidemia, did not show any risk to the postoperative renal outcome.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Prediction of outcome in patients undergoing cardiac surgery on cardiopulmonary bypass using procalcitonin
    H Dörge
    FA Schöndube
    P Dörge
    R Seipelt
    M Voss
    M Grossmann
    BJ Messmer
    Critical Care, 3 (Suppl 2):
  • [2] Effects of Cardiopulmonary Bypass on Renal Perfusion, Filtration, and Oxygenation in Patients Undergoing Cardiac Surgery
    Lannemyr, Lukas
    Bragadottir, Gudrun
    Krumbholz, Vitus
    Redfors, Bengt
    Sellgren, Johan
    Ricksten, Sven-Erik
    ANESTHESIOLOGY, 2017, 126 (02) : 205 - 213
  • [3] The effect of pulsatile cardiopulmonary bypass on the need for haemofiltration in patients with renal dysfunction undergoing cardiac surgery
    Farid, Shakil
    Povey, Hannah
    Anderson, Simon
    Nashef, Samer A. M.
    Abu-Omar, Yasir
    PERFUSION-UK, 2016, 31 (06): : 477 - 481
  • [4] Cardiac surgery with cardiopulmonary bypass in patients with chronic renal failure
    Durmaz, I
    Büket, S
    Atay, Y
    Yagdi, T
    Özbaran, M
    Boga, M
    Alat, I
    Güzelant, A
    Basarir, S
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (02): : 306 - 315
  • [5] Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass
    Tsunehisa Tsubokawa
    Syuichi Ishizuka
    Kyoko Fukumoto
    Kazuyuki Ueno
    Ken Yamamoto
    Journal of Anesthesia, 2013, 27 : 243 - 250
  • [6] Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass
    Barbara, David W.
    Mauermann, William J.
    Neal, James R.
    Abel, Martin D.
    Schaff, Hartzell V.
    Winters, Jeffrey L.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (03): : 668 - 680
  • [7] The outcome of pediatric patients undergoing congenital cardiac surgery under pulsatile cardiopulmonary bypass in different frequencies
    Li, Guanhua
    Jiang, Wen
    Zhang, Yu
    Zhang, Xiaohua
    Chen, Jimei
    Zhuang, Jian
    Zhou, Chengbin
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1553 - 1561
  • [8] Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass
    Tsubokawa, Tsunehisa
    Ishizuka, Syuichi
    Fukumoto, Kyoko
    Ueno, Kazuyuki
    Yamamoto, Ken
    JOURNAL OF ANESTHESIA, 2013, 27 (02) : 243 - 250
  • [9] Cardiopulmonary bypass alters the pharmacokinetics of propranolol in patients undergoing cardiac surgery
    Carmona, MJC
    Malbouisson, LMS
    Pereira, VA
    Bertoline, MA
    Omosako, CEK
    Le Bihan, KB
    Auler, JOC
    Santos, SRCJ
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (05) : 713 - 721
  • [10] Pharmacokinetics of dexmedetomidine in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass
    Kim, Eun-Hee
    Choi, Byung-Moon
    Kang, Pyoyoon
    Lee, Ji-Hyun
    Kim, Hee-Soo
    Jang, Young-Eun
    Ji, Sang-Hwan
    Noh, Gyu-Jeong
    Cho, Joo-Youn
    Kim, Jin-Tae
    PEDIATRIC ANESTHESIA, 2023, 33 (04) : 303 - 311